Preventing Death in T2D and DKD Patients: What Is the Primary Target of Treatment?
Target Audience
Learning Objectives
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- key safety and efficacy data for therapies to prevent CV events in patients with DKD in T2D
- Have greater competence related to
- preventing CV disease progression in patients with DKD in T2D
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Nursing Contact Hours
- 0.50 Participation
Moderator
Matthew R. Weir, MD
Professor of Medicine
University of Maryland School of Medicine
Baltimore, Maryland
Panelists
George Bakris, MD
Professor of Medicine
Director
AHA Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, Illinois
Kenneth Mahaffey, MD
Professor
Stanford University School of Medicine
Stanford, California
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!